farnesol has been researched along with undecaprenyl pyrophosphate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, SY; Chen, AP; Chen, CT; Liang, PH; Lin, YC; Sun, YS; Wang, AH | 1 |
| Kuroda, M; Nagasaki, S; Ohta, T | 1 |
2 other study(ies) available for farnesol and undecaprenyl pyrophosphate
| Article | Year |
|---|---|
Substrate and product specificities of cis-type undecaprenyl pyrophosphate synthase.
Topics: Alkyl and Aryl Transferases; Binding Sites; Escherichia coli Proteins; Farnesol; Hemiterpenes; Hydrophobic and Hydrophilic Interactions; Kinetics; Models, Molecular; Molecular Weight; Mutagenesis, Site-Directed; Organophosphorus Compounds; Polyisoprenyl Phosphates; Protein Conformation; Recombinant Fusion Proteins; Sesquiterpenes; Substrate Specificity | 2005 |
Sesquiterpene farnesol inhibits recycling of the C55 lipid carrier of the murein monomer precursor contributing to increased susceptibility to beta-lactams in methicillin-resistant Staphylococcus aureus.
Topics: beta-Lactamases; beta-Lactams; Biological Transport; Cell Wall; Farnesol; Methicillin Resistance; Mevalonic Acid; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Peptidoglycan; Polyisoprenyl Phosphates; Staphylococcus aureus; Xanthophylls | 2007 |